#CholesterolLowering #LowerCholesterol #CholesterolRemedies #CholesterolExplained #CholesterolTreatment #CholesterolReduction #CholesterolControl #VitaminB3 #FishOil #CodLiverOil
Keys, A. Atherosclerosis: A problem in the new public health Journal of Mt. Sinai Hospital. 20, 118-139, 1953 “Lancet. 1989. Jan. 28;1(8631):188-91 * Braz. J. Med. Biol. Res. 2002. Jan;35(1):1-9 * Prev. Med. 1990. Nov:19)6):614-22 * Int. J. Epidem. 1990. Dec;19(4):820-4 idI n. J. Epidem. 1980 Sep;9(3):227-31 ‘Lancet. 1985 Feb. 9:1(8424):307-9 * J. Natl. Cancer Inst. 1996. Oct 2:88(19) 1375-82 ” Anticancer Res. 1990. Sept-Oct.;10(5a): 1307-11 '’ Cancer Causes Control. 1998. Aug:9(4):425-32 '' Simons, M. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J. of Cell. Biology. 2000. Oct. 2;151(1):1143-54. * Arteriolsclerosis. Throm. Vasc. Biol. 2004;24:806-15 * Smith, D.F. Southern Med. J. 96(12):1265-1267, Dec. 2003. * Muldoon, M.F. Immune systems differences in men with hypo- or hypercholesterolemia. Clin. Immunol. Immunopathol. 1997;84:145-9 ° [ribarren, C. Serum total cholesterol and risk of hospitalization , and death from respiratory disease. Intern. J. of Epidem. 26. 1191-1202. 1997 ° Iribarren, C. Cohort study of serum total cholesterol and in-hospital incidence of infectious disease. Epidem. and Infection. 121. 335-47. 1998 * Netera, M.G. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and server Gram-negative infections. J. Clin. Invest. 1996;97:1366-72 'S Accessed from: www.americanheart.org/presenter.jhtml?identifier=4638. Accessed 4.2.06